TABLE 1.
Baseline clinical characteristics.
| N | 278 |
| Age (year) | 74.9 ± 13.7 |
| BMI (kg/m2) | 25.4 ± 5.0 |
| Female | 133 (47.8) |
| CAD | 119 (42.8) |
| Previous open-heart surgery | 91 (32.7) |
| Previous tricuspid valve surgery (repair) | 5 (1.8) |
| Previous TAVR | 25 (9.0) |
| Previous mitral TEER | 25 (9.0) |
| Previous TTVr | 10 (3.6) |
| Severe renal failure (GFR < 30 mL/min/1.73 m2) | 123 (44.2) |
| Creatinine (umol/l) | 107 (85–155) |
| NT-proBNP (pg/mL) | 4,580 (2,203–4,580) |
| Chronic pneumopathy | 52 (18.7) |
| Malignancy | 31 (11.2) |
| Atrial fibrillation | 189 (68.0) |
| ACHD | 10 (3.6) |
| Acute TR | 13 (4.7) |
| OHT/VAD | 14 (5.0) |
| RV Lead | 81 (29.1) |
Results are expressed as percentage for categorical variables and mean (± SD) or median. (IQR) for continuous variables or number of patients (percentage) for categorical data. CAD, coronary artery disease; TAVR, transcatheter aortic valve replacement; mitral TEER, mitral transcatheter edge-to-edge repair; TTVr, transcatheter tricuspid valve repair; ACHD, adult congenital heart disease; OHT, orthotopic heart transplantation; VAD, ventricular assist device; Chronic pneumopathy, COPD or interstitial lung disease.